Cargando…
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
Background: COVID-19 convalescent plasma (CCP) has been considered internationally as a treatment option for COVID-19. CCP refers to plasma collected from donors who have recovered from and made antibodies to SARS-CoV-2. To date, convalescent plasma has not been collected in South Africa. As other i...
Autores principales: | Glatt, Tanya Nadia, Hilton, Caroline, Nyoni, Cynthia, Swarts, Avril, Swanevelder, Ronel, Cowley, James, Mmenu, Cordelia, Moyo-Gwete, Thandeka, Moore, Penny L., Kutama, Munzhedzi, Jaza, Jabulisile, Phayane, Itumeleng, Brits, Tinus, Koekemoer, Johan, Jentsch, Ute, Nelson, Derrick, van den Berg, Karin, Vermeulen, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539971/ https://www.ncbi.nlm.nih.gov/pubmed/34696480 http://dx.doi.org/10.3390/v13102050 |
Ejemplares similares
-
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
por: van den Berg, Karin, et al.
Publicado: (2022) -
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021
por: Cable, Russel, et al.
Publicado: (2022) -
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022
por: Bingham, Jeremy, et al.
Publicado: (2022) -
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.
por: Sykes, Wendy, et al.
Publicado: (2021) -
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)